// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

The Spot Sign and Tranexamic Acid on Preventing Intracerebral Hemorrhage Growth - AUStralasia Trial

Atte Meretoja - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Tranexamic acid

Ischemic Stroke in Patients with Mechanical Heart Valve off Anticoagulation After Intracranial Hemorrhage

Holly Hinson - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Early Results of the AxiumTM MicroFX for Endovascular Repair of IntraCranial Aneurysm (AMERICA) Study: A Multicenter, Prospective Observational Registry

Kyle M Fargen - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Non Randomized Comparison between Intra-sinus Thrombolysis Alone versus Mechanical Thrombectomy with/without Intra-sinus Thrombolysis for Treatment of Multifocal Cerebral Venosus Sinus Thrombosis

Chirantan Banerjee - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Mechanical Thrombectomy for Cerebral Venous Sinus Thrombosis: A Multi-center Experience

Fazeel Siddiqui - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Prevention in Iscemic Stroke with Antiphospholipid Syndrome

Kazuyuki Iijima - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Aspirin

F11 Receptor Antagonists as Therapeutic Agents for Atherosclerosis and Thrombosis

Yan Li - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Validation of the Factors Affecting Basal and Fluctuating Warfarin Doses in the Same Individual Throughout the Year in Japanese Patients

Haruko Yamamoto - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Arm Ischemic Preconditioning Prevents Stroke Recurrence in Octogenarians with Intracranial Arterial Stenosis

Sanjay Konakondla - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Stroke and Pulmonary Embolism, Clinical Features, Risk Factors and Outcome

Alejandro Rabinstein - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Recurrent Thromboembolic Events After Ischemic Stroke in Patients with Cancer

Samuel Singer - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Open-label Phase I Clinical Study to Assess the Safety and Efficacy of Cilostazol in Patients Undergoing Carotid Artery Angioplasty and Stent Placement

Haralabos Zacharatos - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

Headache and Cerebral Venous Thrombosis

Erwin Chiquete - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Persistently Elevated Factor VIII in Acute Ischemic Stroke is Associated With Higher CRP, Lower Baseline NIHSS, and Longer Length of Hospital Stay

Amelia K Boehme - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

FVIII

A Canine Model of Acute Segmental Vertebral Artery Embolism

Bin Du - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Left Atrial Appendage Volume is Increased in More Than Half of Patients With Cryptogenic Stroke

Ritva Vanninen - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Safety of Venous Thromboembolism Prophylaxis in Intracranial Hemorrhage Patients with External Ventricular Drains

Maximo Jovine - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Enoxaparin

Utilizing Concurrent Chart Review With Electronic Medical Record to Improve Stroke Core and Quality Measures

Jenny Fung - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Stroke Related Limb Weakness Confers Thrombotic Complications With PICC Lines

Ravjot Sodhi - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Prevalence of Systemic Inflammatory Response Syndrome and its Impact on Outcome in Acute Ischemic Stroke Patients Receiving IV tPA Therapy

Amelia K Boehme - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Copyright © 2026. QuantiNova All rights reserved